| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $177K | +14.2% | +24.6% |
| Cost of Revenue | $399K | +0.8% | +76.5% |
| Gross Profit | -$222K | +7.9% | -164.3% |
| R&D Expense | $323K | -15.4% | +8.4% |
| SG&A Expense | $1.4M | +17.2% | -25.7% |
| Operating Income | -$2.2M | -8.3% | +6.4% |
| Net Income | -$741K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $149K | +22.1% | -92.3% |
| Accounts Receivable | $582K | +129.1% | +823.8% |
| Current Assets | $1.4M | -36.2% | -66.4% |
| Total Assets | $1.5M | -35.6% | -65.7% |
| Current Liabilities | $5.0M | -18.7% | -73.1% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.8M | — | — |
| Capital Expenditures | $8K | — | — |
| Investing Cash Flow | $2.4M | — | — |
| Financing Cash Flow | $3.4M | — | — |
| Free Cash Flow | -$5.8M | — | — |
| -124.8% |
| +64.0% |
| EPS (Basic) | -$0.01 | -114.3% | +85.7% |
| EPS (Diluted) | -$0.01 | -114.3% | +85.7% |
| $2.3M |
| — |
| +0.6% |
| Total Liabilities | $5.4M | -11.9% | -70.8% |
| Stockholders' Equity | -$3.9M | -2.6% | +72.4% |